UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice

Dermatology and therapy, 2023-09, Vol.13 (9), p.1893-1907

2023

Volltextzugriff (PDF)

Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials

JEADV clinical practice, 2023-12, Vol.2 (4), p.753-763

2023

Volltextzugriff (PDF)

Label-free in vitro visualization and characterization of caveolar bulbs during stimulated re-epithelialization

Analytical and bioanalytical chemistry, 2014-11, Vol.406 (27), p.6993-7002

2014

Volltextzugriff (PDF)

51876 Impact of Long-Term Abrocitinib Treatment on Patient-Reported Outcomes and Quality of Life for Approximately 2 Years in Patients With Moderate-to-Severe Atopic Dermatitis: An Interim Analysis of JADE EXTEND, a Long-Term Extension Study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB233-AB233

2024

Volltextzugriff (PDF)

52853 Impact of Baseline Disease Severity on the Long-Term Efficacy of Abrocitinib Treatment in Patients With Moderate-To-Severe Atopic Dermatitis: Interim Analysis of the Long-Term Extension JADE EXTEND Study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB232-AB232

2024

Volltextzugriff (PDF)

44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB181-AB181

2023

Volltextzugriff (PDF)

44095 Response to Abrocitinib up to Week 96 According to Short-Term Response: A Post Hoc Analysis of the JADE-EXTEND Phase 3 Trial

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB218-AB218

2023

Volltextzugriff (PDF)

P81 Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_4)

2023

Volltextzugriff (PDF)

423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii41-ii42

2024

Volltextzugriff (PDF)

424 Effect of abrocitinib vs. dupilumab on skin pain: an analysis of the phase 3 JADE COMPARE and JADE DARE trials

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

351 Examining the relationships among abrocitinib treatment, itch, skin pain and dermatology-specific quality of life in patients with atopic dermatitis: a mediation modelling analysis

British journal of dermatology (1951), 2023-01, Vol.188 (Supplement_2)

2023

Volltextzugriff (PDF)

Effect of abrocitinib vs. dupilumab on skin pain: an analysis of the phase 3 JADE COMPARE and JADE DARE trials

British journal of dermatology (1951), 2023, Vol.188 (Suppl. 3)

2023

Volltextzugriff (PDF)

Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Dermatology (Basel), 2023-12, Vol.240 (2), p.243-253

2023

Volltextzugriff (PDF)

Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND

Skin (Milwood, N.Y.), 2024-01, Vol.8 (1), p.s329

2024

Volltextzugriff (PDF)

Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis

Skin (Milwood, N.Y.), 2023-03, Vol.7 (2), p.s154

2023

Volltextzugriff (PDF)

An Investigation of Place Attachment for Outdoor Educators with Pro-Environmental Behaviors: A Phenomenological Study

Watkins, Melissa

2017

Volltextzugriff (PDF)

Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis

Skin (Milwood, N.Y.), 2023-03, Vol.7 (2), p.s151

2023

Volltextzugriff (PDF)

Medication Management in Primary and Secondary Schools

American journal of pharmaceutical education, 2006, Vol.70 (1), p.7, Article 7

2006

Volltextzugriff (PDF)

Medication Management in Primary and Secondary Schools

American journal of pharmaceutical education, 2006-01, Vol.70 (1), p.G1

2006

Volltextzugriff (PDF)

A 69-year-old Man With Gastrointestinal Exsanguination

Journal of emergency nursing, 2011-07, Vol.37 (4), p.363-364

2011

Volltextzugriff (PDF)

Medication management in primary and secondary schools

American journal of pharmaceutical education, 2006-02, Vol.70 (1), p.7-7

2006

Volltextzugriff (PDF)

Medication Management in Primary and Secondary Schools: Evaluation of Mental Health Related In-Service Education in Local Schools

The Journal of school nursing, 2008-08, Vol.24 (4), p.239-248

2008

Volltextzugriff (PDF)

The management of private conservation lands by land trusts in Canada

Watkins, Melissa Jane

2008

Volltextzugriff (PDF)

The Use of Antidepressants in School-Age Children

The Journal of school nursing, 2005-12, Vol.21 (6), p.318-322

2005

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(190)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(242)

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(116)
Humans
(84)
Female
(50)
Male
(50)
Adult
(30)
Animals
(30)
Social Sciences
(23)
Middle Aged
(22)
Aged
(18)
Covid-19
(18)
Neurosciences & Neurology
(18)
Neurosciences
(15)
Science & Technology - Other Topics
(15)
Adolescent
(14)
Biological And Medical Sciences
(14)
Multidisciplinary Sciences
(14)
Medical Sciences
(13)
Patients
(13)
Child
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice

Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials

Label-free in vitro visualization and characterization of caveolar bulbs during stimulated re-epithelialization

51876 Impact of Long-Term Abrocitinib Treatment on Patient-Reported Outcomes and Quality of Life for Approximately 2 Years in Patients With Moderate-to-Severe Atopic Dermatitis: An Interim Analysis of JADE EXTEND, a Long-Term Extension Study

52853 Impact of Baseline Disease Severity on the Long-Term Efficacy of Abrocitinib Treatment in Patients With Moderate-To-Severe Atopic Dermatitis: Interim Analysis of the Long-Term Extension JADE EXTEND Study

44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study

44095 Response to Abrocitinib up to Week 96 According to Short-Term Response: A Post Hoc Analysis of the JADE-EXTEND Phase 3 Trial

P81 Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND

423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial

542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis

424 Effect of abrocitinib vs. dupilumab on skin pain: an analysis of the phase 3 JADE COMPARE and JADE DARE trials

351 Examining the relationships among abrocitinib treatment, itch, skin pain and dermatology-specific quality of life in patients with atopic dermatitis: a mediation modelling analysis

Effect of abrocitinib vs. dupilumab on skin pain: an analysis of the phase 3 JADE COMPARE and JADE DARE trials

Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND

Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis

An Investigation of Place Attachment for Outdoor Educators with Pro-Environmental Behaviors: A Phenomenological Study

Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis

Medication Management in Primary and Secondary Schools

Medication Management in Primary and Secondary Schools

A 69-year-old Man With Gastrointestinal Exsanguination

Medication management in primary and secondary schools

Medication Management in Primary and Secondary Schools: Evaluation of Mental Health Related In-Service Education in Local Schools

The management of private conservation lands by land trusts in Canada

The Use of Antidepressants in School-Age Children

Suchergebnisse filtern